<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00298064</url>
  </required_header>
  <id_info>
    <org_study_id>INST 0548C</org_study_id>
    <nct_id>NCT00298064</nct_id>
  </id_info>
  <brief_title>Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer</brief_title>
  <official_title>Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Tissue Repository will search for cases, pull slides, Paraffin-embedded tissue (PET)
      blocks.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is done to gather preliminary data for determining the best way to test EGFR
      expression in patients with cervical cancer who will receive treatment with EGFR inhibitors
      in the future.

      This study is designed to obtain preliminary data of genomic and phenotypic alterations of
      the EGFR pathway in high grade cervical intraepithelial lesions (HG-SIL) and invasive
      cervical cancers (CC) to be used later for therapeutic guidance and to evaluate genomic
      (over-expression, amplification, point mutations, etc.) and phenotypic alterations of other
      transduction pathways interacting with the EGFR pathway.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2005</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <enrollment type="Actual">300</enrollment>
  <condition>Cervical Cancer</condition>
  <condition>Cervix</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Tissue Repository</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Samples from patients diagnosed with HG-SIL (n=300) and CC (n=300) with a follow-up of
             at least 24 months, existing at the Department of Pathology will be retrieved by the
             Tissue Repository, de-identified them and provided with code numbers that will not be
             linked to patient's data.

        Exclusion Criteria:

          -  None Specified.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Verschraegen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2006</study_first_submitted>
  <study_first_submitted_qc>February 28, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2006</study_first_posted>
  <last_update_submitted>May 10, 2016</last_update_submitted>
  <last_update_submitted_qc>May 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical cancer</keyword>
  <keyword>EGFR</keyword>
  <keyword>cervical</keyword>
  <keyword>genomic</keyword>
  <keyword>DNA</keyword>
  <keyword>markers</keyword>
  <keyword>prognostic</keyword>
  <keyword>gene</keyword>
  <keyword>epidermal growth factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

